April 25-27, 2023
11:00AM-1:30 ESTOnline Training CourseWho Should Attend?
- Medicinal chemists, organic chemists, bioorganic chemists, Discovery Scientists, Therapeutic Areas such as (but not limited too) Oncology, CNS, Cardiovascular, Renal, Metabolism and Respiratory
- Junior, Senior Scientists and managers involved in the development of therapeutic oligonucleotide conjugates in pharma and biotech companies. (Chemistry: Discovery Sciences, Therapeutic Areas for example: Cardiovascular, Renal, Metabolism, Respiratory)
- Junior, Senior Scientists and managers that have recently been re-assigned or joined into roles in the development of therapeutic oligonucleotide conjugates in pharma and biotech companies. This as a result of the renewed focus on RNAi, ASO therapeutics.
- Junior, Senior Scientists and managers that are interested to change roles to become an active player in the development of therapeutic oligonucleotide conjugates in pharma and biotech companies. This as a result of the renewed focus on RNAi, ASO therapeutics.